bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
6.15
-0.42 (-6.33%)
At close: Oct 1, 2026, 4:00 PM EDT
6.01
-0.13 (-2.20%)
Pre-market: Oct 2, 2026, 8:41 AM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$103,526
Profits / Employee
-$266,408
Market Cap
3.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Insight Molecular Diagnostics | 58 |
| Advanced Biomed | 31 |
BIAF News
- 2 days ago - BioAffinity, AvMEDICAL deliver joint exhibition of CyPath Lung - TheFly
- 2 days ago - bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL - Business Wire
- 3 days ago - bioAffinity Technologies Proxy statement: Proxy filing - Filings
- 10 days ago - BioAffinity to present clinical, veteran-focused data on CyPath Lung - TheFly
- 10 days ago - bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference - Business Wire
- 14 days ago - bioAffinity Technologies Inc trading resumes - TheFly
- 14 days ago - bioAffinity Technologies Inc trading halted, volatility trading pause - TheFly
- 15 days ago - BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung - TheFly